SCHEMBL5367197

SCHEMBL5367197

O=C1Nc2ccc(I)cc2C1=Cc1c[nH]cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
RAF1 P04049 3/20 0.52
MAPK1 P28482 3/20 0.52
APP P05067 2/20 0.52
MAP1LC3B Q9GZQ8 2/20 0.52
NTRK1 P04629 2/20 0.52
PIM1 P11309 2/20 0.52
PIM3 Q86V86 2/20 0.52
PLK4 O00444 2/20 0.52
GMNN O75496 2/20 0.52
LMNA P02545 2/20 0.52
TP53 P04637 2/20 0.52
POLB P06746 2/20 0.52
CYP3A4 P08684 2/20 0.52
NFKB1 P19838 2/20 0.52
MTOR P42345 2/20 0.52
PMP22 Q01453 2/20 0.52
EGFR P00533 1/20 0.52
ARAF P10398 1/20 0.52
BRAF P15056 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727946 0.84 PDPK1 (0.55) MAPTAPPMAP1LC3BNTRK1PLK4
SCHEMBL7878729 0.84 LRRK2 (0.58) EGFRTGM2PDGFRBRETLRRK2
SCHEMBL14519137 0.84 LRRK2 (0.58) EGFRTGM2PDGFRBRETLRRK2
SCHEMBL5849994 0.84 RET (0.55) MAPK1NTRK1PIM1PIM3PLK4
SCHEMBL5728661 0.84 RET (0.55) MAPK1NTRK1PIM1PIM3PLK4
SCHEMBL5727942 0.84 PDPK1 (0.55) MAPTAPPMAP1LC3BNTRK1PLK4
Su-9516 SCHEMBL25386665 0.81 TLK2 (0.61) MAPTMAPK1NTRK1PIM1PIM3
Su-9516 SCHEMBL19424245 0.81 TLK2 (0.61) MAPTMAPK1NTRK1PIM1PIM3
Su-9516 SCHEMBL30567582 0.81 TLK2 (0.61) MAPTMAPK1NTRK1PIM1PIM3
SCHEMBL2998488 0.81 GSK3B (0.65) MAPTMAPK1NTRK1PLK4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MAPT 3048/4885RAF1 245/4885MAPK1 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.